Advertisement

Comprehensive investigations are required to manage cardiac disease in myotonic dystrophy 2

  • Josef FinstererEmail author
Letter to the Editor
  • 14 Downloads

Keywords

Myotonic dystrophy Heart Arrhythmias Heart failure Echocardiography Sudden cardiac death Treatment 

Notes

Compliance with ethical standards

Conflict of interest

The author declars that there is no conflicts of interest.

Ethical approval

International ethical standards for investigating humans were obeyed.

Informed consent

Informed consent was obtained from all included patients.

References

  1. 1.
    Pericú S, Bjelica B, Aleksic K, Kovacevic M, Cvitan E, Mandic Stojmenovic G, Rakocevic Stojanovic V (2018) Heart involvement in patients with myotonic dystrophy type 2. Acta Neurol Belg.  https://doi.org/10.1007/s13760-018-1052-3 Google Scholar
  2. 2.
    Park SJ, Cho SW, Kim SM, Ahn J, Carriere K, Jeong DS, Lee SC, Park SW, Choe YH, Park PW, Oh JK (2018) Assessment of myocardial fibrosis using multimodality imaging in severe aortic stenosis: comparison with histologic fibrosis. JACC Cardiovasc Imaging.  https://doi.org/10.1016/j.jcmg.2018.05.028 Google Scholar
  3. 3.
    Finsterer J (2009) Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol ;30:659–681CrossRefGoogle Scholar
  4. 4.
    Captur G, Nihoyannopoulos P (2010) Left ventricular non-compaction: genetic heterogeneity, diagnosis and clinical course. Int J Cardiol 140:145–153CrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2019

Authors and Affiliations

  1. 1.Krankenanstalt Rudolfstiftung, Messerli InstituteVeterinary University of ViennaViennaAustria

Personalised recommendations